ALLO
#2739
Allogene Therapeutics, Inc. - Common Stock
1.9 0 USD
+0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.70%
Variación mensual
-1.04%
Variación en los últimos 6 meses
+18.75%
Cambio anual
+53.23%
Cierres anteriores
1.8 5
Open
1.9 2
Mínimo
1.9 0
High
1.9 2
Volumen
122
Financials
- Market Capitalization 655.79 M
- Employee 152
- Founded 2017
- CEO N/A
- Website www.allogene.com
- Headquarter California, United States
- FIGI BBG00KHRRDX3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.57
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2715 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.41 USD | -4.65% | -6.87% | +7.54% | -11.38% | 673.70 M USD | ||
| 2732 |  CRMD CorMedix Inc. - Common Stock | 8.42 USD | +1.81% | -4.97% | -2.77% | -25.49% | 660.56 M USD | ||
| 2741 |  PTCT PTC Therapeutics, Inc. - Common Stock | 78.84 USD | +1.00% | -11.43% | +4.34% | +63.06% | 653.97 M USD | ||
| 2746 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 6.21 USD | 0.00% | -2.66% | -5.19% | +918.03% | 651.37 M USD |